A unit of AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, pleaded guilty this week to selling pre-filled syringes of cancer drugs prepared in ways that violated federal rules, agreeing to pay penalties of $260 million.
Trending:
AmerisourceBergen pleads guilty over syringes, to pay $260M